More on RXRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+38.9% Growth)
- Ratings (4.0 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Recursion Pharmaceuticals (NQ:RXRX)
Delayed: 3.47 -0.69 (16.59%)
Prev. Close $4.16  
Open$4.11 
52 Wk High$ 
52 Wk Low$ 
Day High$4.19 
Day Low$3.44 
P/E N/A  
EPS$ 
Volume40,699,628 

Friends, Peers and Foes (?): TEM, ABSI, CERT, SDGR, PACB (more...)

Oct 16, 2026 08:43 AM Recursion Pharmaceuticals (RXRX) PT Raised to $5.90 at Morgan Stanley
Oct 15, 2026 05:31 PM Form 424B5 RECURSION PHARMACEUTICAL
Oct 15, 2026 08:47 AM Form 8-K RECURSION PHARMACEUTICAL For: Oct 15
Oct 15, 2026 08:46 AM Sanofi options Recursion drug candidate, triggering $10M payment
Oct 15, 2026 08:45 AM Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
Oct 15, 2026 08:31 AM Recursion prices $200M stock offering at $3.25 per share
Oct 15, 2026 08:30 AM Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
Oct 15, 2026 08:23 AM Recursion raises $200M, reports clinical updates and Sanofi milestone
Oct 15, 2026 08:22 AM Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
Oct 15, 2026 08:20 AM Form 424B5 RECURSION PHARMACEUTICAL
View All Articles

Entities mentioned with RXRX

View All Entities